Open AccessImiquimod enhances anti-lymphoma response in a tumor cell lysate vaccine and inhibits tumor cells growth.
Author(s) -
Claudia Mongini,
De Toro Julieta,
Hershlik Leticia,
Gravisaco Mar�a,
Waldner Claudia,
Di Sciullo Paula
Publication year - 2013
Publication title -
frontiers in immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.646
H-Index - 124
ISSN - 1664-3224
DOI - 10.3389/conf.fimmu.2013.02.01162
Subject(s) - imiquimod , medicine , splenocyte , lymphoma , adjuvant , cd8 , cytotoxicity , pharmacology , immunology , apoptosis , cancer research , immune system , biology , in vitro , biochemistry
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom